Funding for this research was provided by:
Received: 4 February 2022
Accepted: 29 December 2022
First Online: 14 January 2023
: This retrospective study was performed in accordance with ethical principles that have their origin in the Declaration of Helsinki and conducted in adherence to the study Protocol. The study was exempt from institutional review board or ethics committee approval per Exemption 4 of the Office for Human Research Protections Regulations for the Protection of Human Subjects (45 CFR 46) as it used only deidentified claims data from the United States Department of Veterans Affairs. Deidentification and exemption from 45 CFR 46 was determined by a third-party consultant (dEpid/dt Consulting, Inc., Pleasant Ridge, MI). The data is licensed under an agreement with the VHA and not publicly available. Expert determination of statistical deidentification was in compliance with Section 164.514(b) of the Health Insurance Portability and Accountability Act (HIPAA) Privacy.
: Not applicable.
: TT reports no conflict of interest.JY, RS, and SParasuraman are employees of Incyte Corporation. CD is an employee of STATinMED LLC, which is a paid consultant of Incyte Corporation. SPandya was an employee of STATinMED LLC at the time of the analysis. This study was funded by Incyte Corporation.